Trispecific Antibodies

Trispecifics are a new type of treatment being studied for multiple myeloma. These medicines are designed to help your body's own immune cells, called T-cells, find and eliminate cancer cells more effectively. They work by connecting to three different markers: two on the multiple myeloma cancer cells and one on your T-cells. This approach aims to provide new options, especially when other treatments haven't worked as well, by boosting your immune system's ability to target cancer. Here you can learn more about how trispecifics work and what they may mean for your treatment.